MYC and glioblastoma: Of note, MYC induction and decreased TP53 levels in Glioblastoma-EVs stimulated normal astrocytes to shift to a senescence-associated secretory phenotype (a tumor-supportive phenotype) to induce a favorable TME for tumorigenic abilities (growth and invasion) [92].